Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.

NCT00192400 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2160
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

MedImmune LLC

Collaborators